Litigation Details for SUPERNUS PHARMACEUTICALS, INC. v. APOTEX INC. (D.N.J. 2022)
✉ Email this page to a colleague
SUPERNUS PHARMACEUTICALS, INC. v. APOTEX INC. (D.N.J. 2022)
Docket | ⤷ Try a Trial | Date Filed | 2022-01-23 |
Court | District Court, D. New Jersey | Date Terminated | 2022-08-01 |
Cause | 35:271 Patent Infringement | Assigned To | Freda L. Wolfson |
Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
Patents | 10,220,042; 6,287,599; 7,722,898; 7,858,122; 7,910,131; 8,617,600; 8,821,930; 9,119,791; 9,351,975; 9,370,525; 9,855,278 | ||
Firms | Saiber, LLC | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in SUPERNUS PHARMACEUTICALS, INC. v. APOTEX INC.
Details for SUPERNUS PHARMACEUTICALS, INC. v. APOTEX INC. (D.N.J. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2022-01-23 | 1 | Complaint | ’975 patent”), 9,370,525 (“the ’525 patent”), 9,855,278 (“the ’278 patent”), and 10,220,042 (“the ’042…/329 Dec. 7 , 2017 , now Pat . No. 10,220,042 , which is a continuation of application… States Patent No. 11,166,960, attached hereto as Exhibit A (“the ’960 patent” or “the patent in suit…expiration of U.S. Patent Nos. 7,722,898 (“the ’898 patent”), 7,910,131 (“the ’131 patent”), 8,617,600 (“…(“the ’600 patent”), 8,821,930 (“the ’930 patent”), 9,119,791 (“the ’791 patent”), 9,351,975 (“the ’975 | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |